AAPL340.42+3.75 (+1.11%) ▲|ABBV272.42+1.06 (+0.39%) ▲|ABT98.49-0.24 (-0.24%) ▼|ACN208.36+11.72 (+5.96%) ▲|ADBE241.05+8.28 (+3.56%) ▲|AMAT509.57-11.08 (-2.13%) ▼|AMD620.68-25.18 (-3.90%) ▼|AMGN407.44-5.64 (-1.37%) ▼|AMT166.73+0.55 (+0.33%) ▲|AMZN254.06-5.86 (-2.25%) ▼|AVGO360.14-16.37 (-4.35%) ▼|AXP308.10+3.85 (+1.27%) ▲|BA187.75-0.57 (-0.30%) ▼|BAC53.61+0.09 (+0.17%) ▲|BKNG159.97+4.10 (+2.63%) ▲|BLK1,065.35-4.28 (-0.40%) ▼|BMY59.58-0.12 (-0.20%) ▼|BNY143.61+0.89 (+0.62%) ▲|BRK-B511.05+4.80 (+0.95%) ▲|C128.08+0.76 (+0.60%) ▲|CAT796.18-17.65 (-2.17%) ▼|CL88.10+0.89 (+1.02%) ▲|CMCSA21.21+0.27 (+1.29%) ▲|COF199.40+3.49 (+1.78%) ▲|COP134.19+4.35 (+3.35%) ▲|COST947.92+5.67 (+0.60%) ▲|CRM227.80+3.24 (+1.44%) ▲|CSCO114.89-2.50 (-2.13%) ▼|CVS87.80-0.15 (-0.17%) ▼|CVX211.55+6.40 (+3.12%) ▲|DE652.58-4.29 (-0.65%) ▼|DHR217.46-1.03 (-0.47%) ▼|DIS107.02+2.27 (+2.17%) ▲|DUK116.84+1.34 (+1.16%) ▲|EMR159.06-0.16 (-0.10%) ▼|FDX291.73+2.69 (+0.93%) ▲|GD329.90+3.27 (+1.00%) ▲|GE305.62+2.00 (+0.66%) ▲|GEV999.35+2.26 (+0.23%) ▲|GILD147.10+0.25 (+0.17%) ▲|GM82.25+1.26 (+1.56%) ▲|GOOG344.86-2.51 (-0.72%) ▼|GOOGL348.29-2.21 (-0.63%) ▼|GS882.59-4.62 (-0.52%) ▼|HD295.47+9.70 (+3.39%) ▲|HON206.60-1.51 (-0.73%) ▼|IBM226.61+6.10 (+2.77%) ▲|INTC107.08-6.04 (-5.34%) ▼|INTU303.88+8.02 (+2.71%) ▲|ISRG415.41+0.89 (+0.21%) ▲|JNJ256.48-1.97 (-0.76%) ▼|JPM331.42+1.84 (+0.56%) ▲|KO87.77+1.95 (+2.27%) ▲|LIN481.70-2.28 (-0.47%) ▼|LLY1,169.60-19.12 (-1.61%) ▼|LMT507.89+8.67 (+1.74%) ▲|LOW188.85+7.31 (+4.03%) ▲|LRCX320.59-8.92 (-2.71%) ▼|MA574.76+4.70 (+0.82%) ▲|MCD236.90+6.02 (+2.61%) ▲|MDLZ60.67+1.29 (+2.17%) ▲|MDT87.75+2.24 (+2.62%) ▲|META720.89-0.42 (-0.06%) ▼|MMM163.58+1.46 (+0.90%) ▲|MO71.42+2.04 (+2.94%) ▲|MRK142.38-0.41 (-0.29%) ▼|MS187.44-2.27 (-1.20%) ▼|MSFT522.61-7.15 (-1.35%) ▼|MU1,035.84-52.16 (-4.79%) ▼|NEE77.37+0.31 (+0.40%) ▲|NFLX71.57+1.87 (+2.68%) ▲|NKE34.74+0.38 (+1.11%) ▲|NOW139.75+1.88 (+1.36%) ▲|NVDA230.48-6.99 (-2.94%) ▼|ORCL135.69-7.87 (-5.48%) ▼|PEP128.34+4.61 (+3.73%) ▲|PFE27.82-0.18 (-0.64%) ▼|PG150.59+2.77 (+1.87%) ▲|PLTR198.78+4.66 (+2.40%) ▲|PM200.50+7.81 (+4.05%) ▲|QCOM176.01-1.11 (-0.63%) ▼|RTX184.32+4.06 (+2.25%) ▲|SBUX93.21-0.37 (-0.40%) ▼|SCHW96.87+1.29 (+1.35%) ▲|SO86.15+0.71 (+0.83%) ▲|SPG199.61+2.02 (+1.02%) ▲|T24.87+0.40 (+1.63%) ▲|TMO651.98-10.08 (-1.52%) ▼|TMUS171.31+3.66 (+2.18%) ▲|TSLA375.00-2.81 (-0.74%) ▼|TXN288.20-0.78 (-0.27%) ▼|UBER70.24+1.79 (+2.62%) ▲|UNH370.95-5.03 (-1.34%) ▼|UNP278.20+3.52 (+1.28%) ▲|UPS94.13+1.84 (+1.99%) ▲|USB57.03+0.86 (+1.53%) ▲|V375.10+3.00 (+0.81%) ▲|VZ46.35+0.58 (+1.27%) ▲|WFC82.03+1.77 (+2.21%) ▲|WMT110.56+2.40 (+2.22%) ▲|XOM168.50+4.45 (+2.71%) ▲|AAPL340.42+3.75 (+1.11%) ▲|ABBV272.42+1.06 (+0.39%) ▲|ABT98.49-0.24 (-0.24%) ▼|ACN208.36+11.72 (+5.96%) ▲|ADBE241.05+8.28 (+3.56%) ▲|AMAT509.57-11.08 (-2.13%) ▼|AMD620.68-25.18 (-3.90%) ▼|AMGN407.44-5.64 (-1.37%) ▼|AMT166.73+0.55 (+0.33%) ▲|AMZN254.06-5.86 (-2.25%) ▼|AVGO360.14-16.37 (-4.35%) ▼|AXP308.10+3.85 (+1.27%) ▲|BA187.75-0.57 (-0.30%) ▼|BAC53.61+0.09 (+0.17%) ▲|BKNG159.97+4.10 (+2.63%) ▲|BLK1,065.35-4.28 (-0.40%) ▼|BMY59.58-0.12 (-0.20%) ▼|BNY143.61+0.89 (+0.62%) ▲|BRK-B511.05+4.80 (+0.95%) ▲|C128.08+0.76 (+0.60%) ▲|CAT796.18-17.65 (-2.17%) ▼|CL88.10+0.89 (+1.02%) ▲|CMCSA21.21+0.27 (+1.29%) ▲|COF199.40+3.49 (+1.78%) ▲|COP134.19+4.35 (+3.35%) ▲|COST947.92+5.67 (+0.60%) ▲|CRM227.80+3.24 (+1.44%) ▲|CSCO114.89-2.50 (-2.13%) ▼|CVS87.80-0.15 (-0.17%) ▼|CVX211.55+6.40 (+3.12%) ▲|DE652.58-4.29 (-0.65%) ▼|DHR217.46-1.03 (-0.47%) ▼|DIS107.02+2.27 (+2.17%) ▲|DUK116.84+1.34 (+1.16%) ▲|EMR159.06-0.16 (-0.10%) ▼|FDX291.73+2.69 (+0.93%) ▲|GD329.90+3.27 (+1.00%) ▲|GE305.62+2.00 (+0.66%) ▲|GEV999.35+2.26 (+0.23%) ▲|GILD147.10+0.25 (+0.17%) ▲|GM82.25+1.26 (+1.56%) ▲|GOOG344.86-2.51 (-0.72%) ▼|GOOGL348.29-2.21 (-0.63%) ▼|GS882.59-4.62 (-0.52%) ▼|HD295.47+9.70 (+3.39%) ▲|HON206.60-1.51 (-0.73%) ▼|IBM226.61+6.10 (+2.77%) ▲|INTC107.08-6.04 (-5.34%) ▼|INTU303.88+8.02 (+2.71%) ▲|ISRG415.41+0.89 (+0.21%) ▲|JNJ256.48-1.97 (-0.76%) ▼|JPM331.42+1.84 (+0.56%) ▲|KO87.77+1.95 (+2.27%) ▲|LIN481.70-2.28 (-0.47%) ▼|LLY1,169.60-19.12 (-1.61%) ▼|LMT507.89+8.67 (+1.74%) ▲|LOW188.85+7.31 (+4.03%) ▲|LRCX320.59-8.92 (-2.71%) ▼|MA574.76+4.70 (+0.82%) ▲|MCD236.90+6.02 (+2.61%) ▲|MDLZ60.67+1.29 (+2.17%) ▲|MDT87.75+2.24 (+2.62%) ▲|META720.89-0.42 (-0.06%) ▼|MMM163.58+1.46 (+0.90%) ▲|MO71.42+2.04 (+2.94%) ▲|MRK142.38-0.41 (-0.29%) ▼|MS187.44-2.27 (-1.20%) ▼|MSFT522.61-7.15 (-1.35%) ▼|MU1,035.84-52.16 (-4.79%) ▼|NEE77.37+0.31 (+0.40%) ▲|NFLX71.57+1.87 (+2.68%) ▲|NKE34.74+0.38 (+1.11%) ▲|NOW139.75+1.88 (+1.36%) ▲|NVDA230.48-6.99 (-2.94%) ▼|ORCL135.69-7.87 (-5.48%) ▼|PEP128.34+4.61 (+3.73%) ▲|PFE27.82-0.18 (-0.64%) ▼|PG150.59+2.77 (+1.87%) ▲|PLTR198.78+4.66 (+2.40%) ▲|PM200.50+7.81 (+4.05%) ▲|QCOM176.01-1.11 (-0.63%) ▼|RTX184.32+4.06 (+2.25%) ▲|SBUX93.21-0.37 (-0.40%) ▼|SCHW96.87+1.29 (+1.35%) ▲|SO86.15+0.71 (+0.83%) ▲|SPG199.61+2.02 (+1.02%) ▲|T24.87+0.40 (+1.63%) ▲|TMO651.98-10.08 (-1.52%) ▼|TMUS171.31+3.66 (+2.18%) ▲|TSLA375.00-2.81 (-0.74%) ▼|TXN288.20-0.78 (-0.27%) ▼|UBER70.24+1.79 (+2.62%) ▲|UNH370.95-5.03 (-1.34%) ▼|UNP278.20+3.52 (+1.28%) ▲|UPS94.13+1.84 (+1.99%) ▲|USB57.03+0.86 (+1.53%) ▲|V375.10+3.00 (+0.81%) ▲|VZ46.35+0.58 (+1.27%) ▲|WFC82.03+1.77 (+2.21%) ▲|WMT110.56+2.40 (+2.22%) ▲|XOM168.50+4.45 (+2.71%) ▲|
15.2 C
New York
Friday, October 9, 2026

Tag: information

newssourceFORcompanyinformationcontent1releasesmarket

Bid Farewell to Investment Confusion: Theinvestmedia.com, with Eight Years of Expert Experience, Builds Hong Kong’s Most Trusted Platform for Account Opening Offer Comparisons and...

HONG KONG, June 16, 2025 /PRNewswire/ -- today announced its goal to become Hong Kong's leading platform for comparing account opening offers and...

Samsung Biologics launches drug screening services, Samsung Organoids

Samsung Organoids to provide data-driven analysis of candidate moleculesSamsung Biologics expands service scope to include preclinical researchINCHEON, South Korea, June 15, 2025 /PRNewswire/ --...

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core assets, including the novel drug olverembatinib (HQP1351) and the investigational EED inhibitor APG-5918, have been reported at the 2025 European Hematology Association (EHA) Annual Congress.

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis...

2025 Meijer LPGA Classic for Simply Give Exceeds Goal, Raising $1.5 Million to Fight Hunger and Feed Communities in Need

GRAND RAPIDS, Mich., June 15, 2025 /PRNewswire/ -- The 11th Meijer LPGA Classic for Simply Give concluded today, crowning Carlota Ciganda as its 2025 champion....

Zenobē and Brampton lead CA$4 billion initiative to electrify transit bus fleet in landmark UK-Canada collaboration

CA$4B to fund one of North America's largest single zero-emission bus initiatives Initiative expected to support 5,000 direct and indirect jobs across U.K. and...

Ahead of the $3 XRP Era, PFMCrypto Launches 2-Day XRP Mining Promotion, $1 Million Giveaway Sparks Community Excitement

As XRP appears poised to surge to $3 in June, leading XRP mining platform PFMCrypto has launched a 48-hour exclusive XRP mining promotion, giving away $1 million USD in rewards to its global user base 
As XRP appears poised to surge to $3 in June, leading XRP mining platform PFMCrypto has launched a 48-hour exclusive XRP mining promotion, giving away $1 million USD in rewards to its global user base

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SVT, SSBK on Behalf of Shareholders

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Announcement regarding the governance of Renault Group

Announcement regarding the governance
of Renault Group

Annonce concernant la gouvernance de Renault Group

Annonce concernant la gouvernance
de Renault Group

HAPPY FATHER’S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Atai Life Sciences N.V. (NASDAQ: ATAI)

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) --

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Atai Life Sciences N.V. (NASDAQ: ATAI) related to the acquisition of Beckley Psytech Limited. Is it a fair deal?

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit.

CAR FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers